{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-010288","form_type":"8-K","ticker":"IONS","cik":"0000874015","company_name":"IONIS PHARMACEUTICALS INC","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.099836+00:00","generated_at":"2026-06-05T07:41:53.382957+00:00","sec_items":["5.02","1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ionis announces Kyle Jenné returns as EVP Commercial; Onaiza Cadoret-Manier departs","bullets":["Kyle Jenné rejoins as executive vice president, commercial, effective Feb 29, 2024.","Onaiza Cadoret-Manier, EVP chief global product strategy and operations officer, leaves for another opportunity.","Cadoret-Manier will remain full-time through March 15, 2024, then serve as advisor.","Advisory agreement pays $12,500/month through Sep 2024, then $6,250/month through Jan 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-010288","json":"https://secwatch.observer/filing/0001140361-24-010288.json","markdown":"https://secwatch.observer/filing/0001140361-24-010288.md","text":"https://secwatch.observer/filing/0001140361-24-010288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/0001140361-24-010288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/ef20022767_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:41:53.382957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3724312bc9","claim":"Kyle Jenné was appointed as executive vice president, commercial at IONIS PHARMACEUTICALS INC.","evidence_excerpt":"Kyle Jenné has rejoined Ionis as executive vice president, commercial","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/0001140361-24-010288-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"rejoined"},{"label":"Role","value":"executive vice president, commercial"}],"fact_type":"executive_change"},{"claim_id":"87c922a422","claim":"Onaiza Cadoret-Manier departed as executive vice president, chief global product strategy and operations officer at IONIS PHARMACEUTICALS INC.","evidence_excerpt":"Onaiza Cadoret-Manier, executive vice president, chief global product strategy and operations officer, is leaving the company to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/0001140361-24-010288-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"leaving"},{"label":"Role","value":"executive vice president, chief global product strategy and operations officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}